Bisoprolol may increase the hypotensive activities of Polythiazide. Hydracarbazine may increase the hypotensive activities of Bisoprolol. Regorafenib may increase the bradycardic activities of Bisoprolol. Magnesium salicylate may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Metolazone is combined with Bisoprolol. Iproniazid may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dinutuximab. Iproclozide may increase the hypotensive activities of Bisoprolol. Remikiren may increase the hypotensive activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Alaproclate. The serum concentration of Bisoprolol can be increased when it is combined with Netupitant. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carbachol. Felbinac may decrease the antihypertensive activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Enzalutamide. Ketanserin may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Amiloride is combined with Bisoprolol. Bisoprolol may increase the hypotensive activities of Dorzolamide. Malathion may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Irbesartan. Bisoprolol may increase the hypoglycemic activities of Glimepiride. Guanfacine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Ketoconazole. The serum concentration of Bisoprolol can be decreased when it is combined with Bosentan. Bisoprolol may decrease the bronchodilatory activities of Bambuterol. Bisoprolol may decrease the bronchodilatory activities of Pirbuterol. Furazolidone may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Streptokinase is combined with Bisoprolol. Bisoprolol may increase the hypotensive activities of Ticrynafen. Nabumetone may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Clobazam. Bisoprolol may increase the hypotensive activities of Terlipressin. The serum concentration of Bisoprolol can be increased when it is combined with Fusidic Acid. Isoxicam may decrease the antihypertensive activities of Bisoprolol. Thiethylperazine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Pasireotide. Bisoprolol may increase the hypotensive activities of Omapatrilat. Mebanazine may increase the hypotensive activities of Bisoprolol. Methylene blue may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Lanreotide. Bisoprolol may increase the hypotensive activities of Phentolamine. Mizoribine may decrease the antihypertensive activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Luliconazole. The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Abiraterone. Bisoprolol may decrease the bronchodilatory activities of Arbutamine. The metabolism of Bisoprolol can be decreased when combined with Ritonavir. Selegiline may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Varenicline. Indobufen may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Levodopa. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Quetiapine. Alfentanil may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Labetalol. The serum concentration of Bisoprolol can be increased when it is combined with Simeprevir. Bisoprolol may increase the orthostatic hypotensive activities of Duloxetine. Diflunisal may decrease the antihypertensive activities of Bisoprolol. Salicylamide may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypoglycemic activities of Gliclazide. Mycophenolate mofetil may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Tolcapone is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Fenoterol. The metabolism of Bisoprolol can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Spironolactone is combined with Bisoprolol. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Temocapril. The serum concentration of Bisoprolol can be increased when it is combined with Ceritinib. Bisoprolol may increase the bradycardic activities of Beractant. Flurbiprofen may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Erythromycin. Bisoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide. Apomorphine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bethanechol. Bisoprolol may increase the orthostatic hypotensive activities of Bunazosin. Decamethonium may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Indenolol. Bisoprolol may increase the bradycardic activities of Ouabain. The metabolism of Bisoprolol can be decreased when combined with Mirabegron. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine. Bisoprolol may increase the bradycardic activities of Midodrine. Triflupromazine may increase the hypotensive activities of Bisoprolol. Ambenonium may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Olmesartan is combined with Bisoprolol. Aripiprazole may increase the hypotensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Procaterol. Methanesulfonyl Fluoride may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Canagliflozin. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Etacrynic acid. The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Sarilumab. Parecoxib may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Amodiaquine. Bisoprolol may increase the hypotensive activities of Hydroflumethiazide. The metabolism of Bisoprolol can be decreased when combined with Rolapitant. Etodolac may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Proscillaridin. Bisoprolol may increase the hypotensive activities of Niguldipine. The metabolism of Bisoprolol can be decreased when combined with Cocaine. Triptolide may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Bupranolol. Indomethacin may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Minoxidil is combined with Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Mifepristone. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Empagliflozin. The metabolism of Bisoprolol can be decreased when combined with Midostaurin. The metabolism of Bisoprolol can be increased when combined with Nevirapine. The metabolism of Bisoprolol can be decreased when combined with Cholecalciferol. Bisoprolol may decrease the bronchodilatory activities of Terbutaline. Bisoprolol may decrease the bronchodilatory activities of Dyphylline. The metabolism of Bisoprolol can be decreased when combined with Ziprasidone. Bisoprolol may decrease the bronchodilatory activities of Salmeterol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Metipranolol. Bisoprolol may increase the hypotensive activities of BQ-123. Clonixin may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Ritodrine. Tadalafil may increase the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isoxsuprine. Bisoprolol may increase the hypoglycemic activities of Glipizide. Methylphenidate may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Theodrenaline. The serum concentration of Bisoprolol can be increased when it is combined with Indalpine. The serum concentration of Bisoprolol can be decreased when it is combined with St. John's Wort. Tacrine may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nesiritide. Benoxaprofen may decrease the antihypertensive activities of Bisoprolol. Avanafil may increase the antihypertensive activities of Bisoprolol. Nicorandil may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Ferulic acid. Octamoxin may increase the hypotensive activities of Bisoprolol. Mesalazine may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Bisoprolol.